Pages that link to "Q38108721"

The following pages link to Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection. (Q38108721):

Displaying 21 items.

• The CD27L and CTP1L Endolysins Targeting Clostridia Contain a Built-in Trigger and Release Factor (Q27684804) (← links)
• Beneficial Microbes: The pharmacy in the gut (Q28067936) (← links)
• Finding alternatives to antibiotics (Q34426004) (← links)
• Antimicrobial activity of lactic acid bacteria in dairy products and gut: effect on pathogens. (Q35229172) (← links)
• A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors (Q35332572) (← links)
• Examination of bacterial inhibition using a catalytic DNA (Q35532061) (← links)
• The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health (Q36151378) (← links)
• Clostridium Difficile Colitis in Trauma Patients - a Global Step by Step Review (Q37668965) (← links)
• Treatment of Clostridium difficile infection in pediatric patients (Q38442257) (← links)
• In vitro antifungal, probiotic, and antioxidant functional properties of a novel Lactobacillus paraplantarum isolated from fermented dates in Saudi Arabia (Q38798953) (← links)
• Bacteriocins synthesized by Bacillus thuringiensis: generalities and potential applications. (Q38875808) (← links)
• The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung. (Q40062783) (← links)
• Modulation of the gut microbiota by prebiotic fibres and bacteriocins (Q41676366) (← links)
• Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol (Q42203724) (← links)
• Beneficial Microbes: The pharmacy in the gut. (Q46055149) (← links)
• Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review (Q49947171) (← links)
• Narrow-Spectrum Antibacterial Agents. (Q53703028) (← links)
• Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? (Q60920164) (← links)
• Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections (Q61812254) (← links)
• APC 678 Reduces Shedding of the Pathogen in a Murine Model (Q64230166) (← links)
• Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile. (Q64941132) (← links)